November 2017 Supplement - Endovascular Today

Table of Contents

Supplement

November 2017 Supplement

Zenith® Fenestrated

The first FDA-approved option for treating ≥ 4mm short-necked infrarenal AAA.

Download PDF

ZFEN Technology: Why It Works and What's in Its Future

By Gustavo S. Oderich, MD

FEVAR: Long-term Data From the Cleveland Clinic

Continued development and application of fenestrated endovascular technology to treat complex aortic disease and directions for the future.

By Matthew J. Eagleton, MD

Ten Steps

A standardized 10-step approach to the planning and sizing of a fenestrated endovascular aortic aneurysm repair.

By Jessica P. Simons, MD, MPH, and Andres Schanzer, MD

Use of ZFEN in Community Practice

The current state of treatment for complex abdominal aortic aneurysms in community practice using the Zenith Fenestrated stent graft.

By Jesse Manunga, MD

Recommendations From a Busy Fenestrated Practice

The top 10 lessons we have learned for optimizing clinical outcomes.

By Gustavo S. Oderich, MD; Emanuel Tenorio, MD, PhD; and Giuliano Sandri, MD

State of the Art in Radiation Safety During Fenestrated EVAR

A discussion of radiation exposure during FEVAR.

By Melissa Kirkwood, MD; David Timaran, MD; and Carlos Timaran, MD

Latest Issues

April 2026

March 2026

February 2026

January 2026

December 2025

View All Issues